NAmur Research Institute for LIfe Sciences
Grégoire WIEERS
Microbiota intervention
Intervention on gut microbiota to reduce antibiotic resistance spreading
Prof. Grégoire Wieërs MD, PhD
UNamur, Faculty of medicine, Department of medicine, Research Unit in Clinical Pharmacology and Toxicology (URPC)
Member of Espace philosophique de Namur (ESPHIN)
Clinician at Clinique Saint-Pierre d'Ottignies
Research portal UNamur | ORCID | LinkedIn
Expertise and research interests
Prof. Grégoire Wieërs is a doctor in medicine, specialist in general internal medicine, and works as a clinician at the Clinique Saint-Pierre d'Ottignies. He holds a PhD in Biomedical and Pharmaceutical Sciences from the UCLouvain. He conducted his doctoral research at the de Duve institute, under the guidance of Prof. Pierre van der Bruggen, in the field of immunity and cancer.
Research projects
- ONGOING Sustainable development in healthcare causes and consequences. Signification, research and teaching.
- Functions of human tumor infiltrating lymphocytes are boosted after ex vivo treatment with two galectin-binding polysaccharides used as investigational human drugs. PhD thesis defended by Grégoire Wieërs on 03/11/2021. Under the supervision of Prof. Pierre van der Bruggen, UCLouvain, de Duve Institute.
Selected publications
Wieërs G, Absil S, Maystadt I, Nicaise C, Modrie P, Sibille FX, Melly L, Dogné JM. Prescribing sustainability: should UN sustainable development goals be part of the medical, pharmacy, and biomedical education? Front Med (Lausanne). 2024 Oct 7;11:1438636.
Grégoire Wieërs, Laurent Ravez. Le développement durable à l’hôpital : aux sources de la bioéthique. Louvain medical. 2024 Janvier
Everard C, Schampaert A, Doyen L, Verbelen V, Marot JC, Wieërs G. Intravenous cefuroxime as a first-line treatment for women hospitalized for pyelonephritis. JAC Antimicrob Resist. 2024 May 6;6(3):dlae071.
Wieërs G, Verbelen V, Van Den Driessche M, Melnik E, Vanheule G, Marot JC, Cani PD. Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing Saccharomyces to a Mixture of Lactobacillus, Bifidobacterium, and Saccharomyces. Front Public Health. 2021 Mar 8;8:578089.
Wieërs G, Belkhir L, Enaud R, Leclercq S, Philippart de Foy JM, Dequenne I, de Timary P, Cani PD. How Probiotics Affect the Microbiota. Front Cell Infect Microbiol. 2020 Jan 15;9:454.
Wieërs G, Demotte N, Godelaine D, Van der Bruggen P. Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines. Cancers (Basel). 2011 Jul 18;3(3):2904-54.
Wieërs G, Gras J, Bourdeaux C, Truong DQ, Latinne D, Reding R. Monitoring tolerance after human liver transplantation. Transpl Immunol. 2007 Feb;17(2):83-93.
